Copyright
©The Author(s) 2017.
World J Gastrointest Oncol. May 15, 2017; 9(5): 209-217
Published online May 15, 2017. doi: 10.4251/wjgo.v9.i5.209
Published online May 15, 2017. doi: 10.4251/wjgo.v9.i5.209
OR | 95%CI (lower) | 95%CI (upper) | P value | |
Overall survival | 0.936 | 0.893 | 0.981 | 0.006 |
T stage | 7.764 | 1.749 | 34.463 | 0.007 |
N stage | 2.552 | 0.851 | 7.651 | 0.095 |
Age | 1.024 | 0.969 | 1.081 | 0.405 |
Systemic recurrence | 0.865 | 0.200 | 3.749 | 0.846 |
Sex | 0.564 | 0.119 | 2.668 | 0.470 |
Local recurrence | 1.841 | 0.193 | 17.562 | 0.596 |
Involved CRM | 0.276 | 0.009 | 8.376 | 0.459 |
KRAS mutation | 1.577 | 0.389 | 6.391 | 0.524 |
CIMP-H | 6.368 | 1.091 | 37.162 | 0.040 |
- Citation: Williamson JS, Jones HG, Williams N, Griffiths AP, Jenkins G, Beynon J, Harris DA. Extramural vascular invasion and response to neoadjuvant chemoradiotherapy in rectal cancer: Influence of the CpG island methylator phenotype. World J Gastrointest Oncol 2017; 9(5): 209-217
- URL: https://www.wjgnet.com/1948-5204/full/v9/i5/209.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v9.i5.209